- Home
- PRME vs IAUX Comparison
PRME vs IAUX Comparison
Compare PRME & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- IAUX
- Stock Information
- Founded
- PRME 2019
- IAUX 2020
- Country
- PRME United States
- IAUX United States
- Employees
- PRME N/A
- IAUX N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- IAUX
- Sector
- PRME Health Care
- IAUX
- Exchange
- PRME Nasdaq
- IAUX Nasdaq
- Market Cap
- PRME 693.5M
- IAUX 775.8M
- IPO Year
- PRME 2022
- IAUX N/A
- Fundamental
- Price
- PRME $5.78
- IAUX $0.99
- Analyst Decision
- PRME Buy
- IAUX Buy
- Analyst Count
- PRME 6
- IAUX 1
- Target Price
- PRME $8.88
- IAUX $1.50
- AVG Volume (30 Days)
- PRME 3.8M
- IAUX 7.0M
- Earning Date
- PRME 11-11-2025
- IAUX 11-11-2025
- Dividend Yield
- PRME N/A
- IAUX N/A
- EPS Growth
- PRME N/A
- IAUX N/A
- EPS
- PRME N/A
- IAUX N/A
- Revenue
- PRME $4,961,000.00
- IAUX $76,622,000.00
- Revenue This Year
- PRME $179.58
- IAUX $79.79
- Revenue Next Year
- PRME N/A
- IAUX $92.04
- P/E Ratio
- PRME N/A
- IAUX N/A
- Revenue Growth
- PRME 739.42
- IAUX 40.21
- 52 Week Low
- PRME $1.11
- IAUX $0.34
- 52 Week High
- PRME $6.94
- IAUX $1.25
- Technical
- Relative Strength Index (RSI)
- PRME 60.95
- IAUX 68.66
- Support Level
- PRME $4.87
- IAUX $0.91
- Resistance Level
- PRME $6.94
- IAUX $1.00
- Average True Range (ATR)
- PRME 0.49
- IAUX 0.06
- MACD
- PRME 0.07
- IAUX -0.00
- Stochastic Oscillator
- PRME 47.88
- IAUX 70.93
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.